Larimar Therapeutics Inc

LRMR.US
Healthcare · Biotechnology
3.83
+0.00 (+0.00%)
USD · NASDAQ

Company Information

Company Name
Larimar Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US5171251003
CIK: 0001374690
CUSIP: 517125100
Currency: USD
Full Time Employees: 71
Phone: 844 511 9056
Fiscal Year End: December
IPO Date: Jun 19, 2014
Description:

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.

Address:

Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004

People

Directors & Officers

Name Title Year Born
Dr. Carole S. Ben-Maimon M.D. CEO, President & Director 1959
Mr. Michael Celano CPA Secretary & CFO 1959
Dr. Gopi Shankar M.B.A., Ph.D. Chief Development Officer 1971
Mr. John Berman Vice President of Finance & Administration NA
Ms. Jennifer Spokes Johansson Vice President of Legal & Compliance NA
Dr. Russell G. Clayton Sr., D.O. Chief Medical Officer 1961
Mr. Francis Michael Conway CPA VP & Controller NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 27, 2026 James E Flynn N/A Purchase 5.00M $5.00 $25.00M
Jul 31, 2025 James E Flynn N/A Purchase 9.38M $3.20 $30.00M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Deerfield Management Co 35.61M Mar 31, 2026 34.28% $1.89 16.34%
Blue Owl Capital Holdings LP 7.12M Mar 31, 2026 6.85% $8.61 4.34%
BlackRock Inc 3.75M Mar 31, 2026 3.61% $0.00 1.92%
Millennium Management LLC 3.63M Mar 31, 2026 3.49% $0.01 -30.37%
Vanguard Group Inc 3.05M Dec 31, 2025 2.93% $0.00 -1.35%
AIGH Capital Management, LLC 3.00M Mar 31, 2026 2.89% $1.84 50.00%
Driehaus Capital Management LLC 2.93M Mar 31, 2026 2.82% $0.10 448.01%
Vanguard Capital Management, LLC 2.87M Mar 31, 2026 2.76% $0.00 0.00%
Dafna Capital Management LLC 2.03M Mar 31, 2026 1.95% $2.08 116.06%
The Goldman Sachs Group Inc 1.56M Mar 31, 2026 1.50% $0.00 15.91%
Deep Track Capital, LP 1.50M Mar 31, 2026 1.44% $0.11 0.00%
RTW INVESTMENTS, LLC 1.50M Mar 31, 2026 1.44% $0.07 -52.00%
Woodline Partners LP 1.40M Mar 31, 2026 1.35% $0.02 74.92%
Geode Capital Management, LLC 1.11M Mar 31, 2026 1.07% $0.00 1.41%
Soleus Capital Management, L.P. 1.07M Mar 31, 2026 1.03% $0.19 0.00%
Point72 Asset Management, L.P. 1.05M Mar 31, 2026 1.01% $0.01 -28.31%
Marshall Wace Asset Management Ltd 933.46K Mar 31, 2026 0.90% $0.00 0.00%
State Street Corp 911.33K Mar 31, 2026 0.88% $0.00 -0.07%
Gem Investment Advisors, LLC 854.23K Mar 31, 2026 0.82% $3.78 204.15%
Qube Research & Technologies 847.64K Mar 31, 2026 0.82% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 2.21M 2.12% ▼ 5.59% Jun 30, 2026
2 iShares Russell 2000 ETF 1.73M 1.67% ▲ 0.60% Jun 30, 2026
3 Heptagon Driehaus US Micro Cap Eq C$ Acc 873.70K 0.84% ▲ 0.41% May 31, 2026
4 Fidelity Enhanced Small Cap Core ETF 814.62K 0.78% ▲ 0.00% Jun 30, 2026
5 CREF Total Global Stock Account R3 757.60K 0.73% ▲ 0.00% May 31, 2026
6 Vanguard Institutional Extnd Mkt Idx Tr 699.47K 0.67% ▲ 47.80% Jun 30, 2026
7 iShares Russell 2000 Growth ETF 622.76K 0.60% ▼ 0.38% Jun 30, 2026
8 MEDICAL BioHealth EUR Acc 521.22K 0.50% ▼ 0.02% May 31, 2026
9 Fidelity Small Cap Index 467.27K 0.45% ▲ 0.80% Apr 30, 2026
10 Russell 2000 Index Non-Lendable Fund 438.22K 0.42% ▲ 69.04% Jun 30, 2026

Financial Highlights

Market Cap: $397.87M
EBITDA: $-172.10M
Book Value: $1.51
Earnings/Share: $-2.02
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -56.92%
ROE (TTM): -109.83%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $218.93M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 103.88M
Shares Float: 59.94M
% Insiders: 114.60%
% Institutions: 8,622.10%
Short % Float: 16.81%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-350.00K
Gross Profit
subtotal
$-350.00K
SG&A
adjust
$-18.27M
R&D
adjust
$-154.22M
Operating Income
subtotal
$-172.50M
Other / Non-Operating Items
adjust
$6.82M
Net Income
subtotal
$-165.67M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about LRMR.US!